- We have a terrific interview with a neurologist that treats Alzheimer's Disease as well as Tubular Sclerotic Epilepsy (caused by mTOR dysfunction, patent pending for SAVA).
- Dr. Edward Boyer speaks with us about his experience with AD.
- He also provides his commentary on Cassava Sciences' simufilam.
Analyst's Disclosure: I/we have a beneficial long position in the shares of SAVA either through stock ownership, options, or other derivatives.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.